Black patients with cancer fare worse with COVID-19, study shows

March 28, 2022

Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]




UT Health San Antonio expands physician assistant studies program in Laredo

March 21, 2022

Will provide more career opportunities for students Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu LAREDO, Texas, March 21, 2022 – UT Health San Antonio’s School of Health Professions invites Webb County students interested in a health career to learn more about its nationally recognized Master of Physician Assistant Studies program. Expanded to Laredo in the summer of […]


Mays Cancer Center executive director testifies before House panel about clinical trial diversity

March 18, 2022

Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 18, 2022) — Ruben A. Mesa, MD, FACP, professor of medicine and executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, testified on clinical trial diversity yesterday (March 17, 2022) before the House Committee on Energy and Commerce. The […]

Photo of Dr. Ruben Mesa, cancer expert, speaking before a House subcommittee


Reuben Harris, PhD, to chair Department of Biochemistry and Structural Biology

March 11, 2022

Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 11, 2021) — Cancer and virology researcher Reuben Harris, PhD, has been named chairman of the Department of Biochemistry and Structural Biology at The University of Texas Health Science Center at San Antonio (UT Health San Antonio). The department is in the Joe R. and Teresa Lozano […]

Microscope in laboratory


Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials

March 10, 2022

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio together with SignalRx Pharmaceuticals Inc. have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division […]




Thoracic surgery team achieves highly coveted ranking for lung, esophageal cancer outcomes

March 10, 2022

Only the most elite programs garner 3-star ratings from the Society of Thoracic Surgeons. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 10, 2022) — The UT Health San Antonio Department of Cardiothoracic Surgery has earned a distinguished three-star rating from the Society of Thoracic Surgeons (STS) for its patient care and lung and […]

Photo of surgery